Jun
2026
Pennsylvania Convention Center, Philadelphia
Visit us
stand 1519
August Bioservices
Exhibitor at CPHI Americas 2026
About Us
Categories
-
Country/Region:United States
-
On CPHI since:2021
-
Certificates:2
-
Employees:50 - 99
Company types
Primary activities
Event information
CPHI Americas 2026
-
2 Jun 2026 - 4 June 2026
-
Pennsylvania Convention Center, Philadelphia
-
Visit us at stand 1519
Products Featured at CPHI Americas 2026
-
Product August Bioservices - End to End (Preclinical to Clinical to Commercial), US-based CDMO Capabilities
This is an overview capabilities brochure of the services and expertise August Bioservices offers to biotech and pharma companies of all sizes. As a growing, US-based provider of expert CDMO services, August is rapidly becoming a preferred partner for clients seeking deep drug development, formulation, sca... -
Product Cell Line Development, 3D Cell Culture and Immuno-Oncology Research (In Vivo)
August Bioservices can support preclinical research needs as well.These case studies highlight capabilities from cell line development, high-throughput multi-parametric cell health assays, 3D cell culture high content screening, wound healing assays, and mouse models to study colon cancer and lymphoma.In a... -
Product Expert Biophysical Characterization with Cutting-Edge Technologies
August Bioservices has a Binding Technologies Toolbox that is second to none. These case studies highlight our biophysical characterization capabilities, including the state-of-the-art TRIC (Temperature Related Intensity Change) technology which can provide new insights into protein-small molecule binding ... -
Product cGMP Manufacturing - Bags, PFS, Vials - Exceptional Range of Sizes and Fill Volumes
August Bioservices can provide clinical and commercial manufacturing fill finish services - with supporting formulation development, scale up and analytical testing capabilities - across a wide range of injectable products, container sizes and fill volumes.
Vials - from 1/2 mL up to 500 mL
Syringes... -
Product CDMO Best Practices from Benches to Batches - How to Transition from Clinical to Commercial Readiness
What you need to seamlessly transition from clinical phases to commercial readiness.
Three unique abilities your CDMO must have to complete your project within your timeline are capability, flexibility and availability.
August Bioservices' Director of Customer Operations, Commercial Devel...
August Bioservices Resources (1)
-
Brochure August Bioservices Capabilities
Welcome to August Bioservices At August Bioservices, we are a US-based, world-class CDMO specializing in sterile injectable drug development and manufacturing. With a full spectrum of capabilities from early-stage formulation to commercial production, we partner with clients to bring life-changing therapies to patients faster. Our team of industry experts, cutting-edge technology, and flexible, scalable solutions are built to meet your product’s unique needs at every stage.


